Your browser doesn't support javascript.
loading
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
Senatore, Fortunato; Jagadeesh, Gowraganahalli; Rose, Martin; Pillai, Venkateswaran C; Hariharan, Sudharshan; Liu, Ququan; McDowell, Tzu-Yun; Sapru, Mohan K; Southworth, Mary Ross; Stockbridge, Norman.
Afiliação
  • Senatore F; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA.
  • Jagadeesh G; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA. Gowra.Jagadeesh@fda.hhs.gov.
  • Rose M; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA.
  • Pillai VC; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Hariharan S; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Liu Q; Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • McDowell TY; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA.
  • Sapru MK; The Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Southworth MR; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA.
  • Stockbridge N; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Bldg 22, Room #4128, Silver Spring, MD, USA.
Am J Cardiovasc Drugs ; 19(2): 227, 2019 04.
Article em En | MEDLINE | ID: mdl-30820768
The author name that previously read.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article